Asia-Focused Biotech SPAC Valuence Merger I Prices US$200 Million IPO

Special purpose acquisition company Valuence Merger Corp. I (Nasdaq: VMCAU) started trading on the Nasdaq Global Market today. The firm aims to raise US$200.0 million in its initial public offering.

The offering consisted of 20.0 million company units at US$10.00 per unit. Each unit contains one Class A common share and one-half of a redeemable warrant. Each whole warrant is exercisable for one common share at US$11.50 per share. The company units are currently trading under the symbol “VMCAU” while the shares and purchase warrants, once trading separately, will be trading under “VMCA” and “VMCAW”, respectively.

SVB Leerink acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day overallotment option to purchase additional 3.0 million units at the same IPO price.

The blank check firm is being led by CEO Sung Yoon Woo, the CEO of South Korean private equity firm Credian Partners. The firm also expects to partner with venture capital firm CrystalBioSciences and Japan-based consulting firm Quantum Leaps,

For its target businesses, the firm said it intends to search for businesses “in Asia (excluding China, Hong Kong, and Macau) with a particular focus… in life sciences and/or sustainable technology.”


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Renewable Energy SPAC Enphys Acquisition Prices Upsized US$300 Million IPO

Blank check company Enphys Acquisition Corp. (Nasdaq: NFYS.U) went public today on the Nasdaq Global...

Wednesday, October 6, 2021, 02:26:00 PM

Singapore-Based A SPAC II Acquisition Prices US$185 Million IPO

Special purpose acquisition company A SPAC II Acquisition Corp. (Nasdaq: ASCBU) started trading on the...

Wednesday, May 4, 2022, 11:35:00 AM

Cannabis SPAC Relativity Acquisition Prices US$125 Million IPO

Special purpose acquisition company Relativity Acquisition Corp. (Nasdaq: RACYU) started trading its securities on the...

Friday, February 11, 2022, 02:17:00 PM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

Tiger Williams-Led SPAC Williams Rowland Acquisition Seeks To Raise US$200 Million In IPO

Special purpose acquisition company Williams Rowland Acquisition Corp. (NYSE: WRACU) went public on the New...

Tuesday, July 27, 2021, 12:21:00 PM